Pennsylvania EMS Department To Participate in Heart Attack Study - News - @ JEMS.com


Pennsylvania EMS Department To Participate in Heart Attack Study

Study participants will receive either a standard IV solution or glucose-insulin-potassium solution for 12 hours.


 
 

Lebanon Daily News | | Monday, August 9, 2010


Life Lion Emergency Medical Service and Penn State Milton S. Hershey Medical Center announced that they have received approval to begin participation in a heart-attack study called the IMMEDIATE Trial.

This National Institutes of Health-sponsored research study will test if an intravenous solution of glucose, insulin and potassium can reduce the likelihood of death from a heart attack, according to a news release from the Derry Township hospital. The study director is Dr. James Leaming.

Patient enrollment will start this month and will continue for up to one year. Patients with symptoms of a heart attack who are at least 30 years old and have positive findings on an EKG done by an EMS paramedic may be enrolled in the trial.

People with signs of heart failure and those receiving dialysis will not be enrolled. Due to the emergency nature of a heart attack, patients will not be able to give informed consent prior to starting the study drug. In the ambulance, the paramedics will notify patients of the study and they can decide to accept or decline participation. More detailed information will be provided at the hospital, and at that time patients can provide informed consent to continue or withdraw.

Study participants will receive either a standard IV solution or glucose-insulin-potassium solution for 12 hours. Which solution received is determined by chance. Neither the patient nor the medical staff will know which one has been assigned. All patients continue to receive standard care normally given.

Previous studies have shown that giving glucose-insulin-potassium as early as possible may protect the heart from damage until further therapies are available. However, there is no guarantee of benefit for trial participants.

Possible side effects include redness or inflammation at the IV site; change in blood sugar levels that may cause weakness, dizziness or thirstiness; change in potassium levels that may result in a rapid heartbeat or dizziness. Patients are monitored for side effects and treated if needed.

Use of the exception from informed consent provision in a study protocol is granted by the Institutional Review Board responsible for the initial and continuing review and approval of the research study. Patients may withdraw from the study at any time, with no disruption in care.



Related Links:


Copyright © 2013 LexisNexis, a division of Reed Elsevier Inc. All rights reserved. Terms and Conditions | Privacy Policy


Connect: Have a thought or feedback about this? Add your comment now
Related Topics: News, research, heart attack

What's Your Take? Comment Now ...

Buyer's Guide Featured Companies

Featured Careers & Jobs in EMS

Get JEMS in Your Inbox

 

Fire EMS Blogs


Blogger Browser

Today's Featured Posts

 

EMS Airway Clinic

Innovation & Advancement

This is the seventh year of the EMS 10 Innovators in EMS program, jointly sponsored by Physio-Control and JEMS.
More >

Multimedia Thumb

Wesleyan Students Hospitalized for Overdose

11 students transported to local hospitals.
Watch It >


Multimedia Thumb

Denver Medic's Family Says Job Stress Contributed to Suicide

Veteran of over 25 years took her own life after a call.
Watch It >


Multimedia Thumb

Denver First Responders Join to Remember Paramedic

Veteran medic took her own life after fatal accident.
Watch It >


Multimedia Thumb

Rigs Going in Service from EMS Today 2015

Snap shots of some of the vehicles at EMS Today that will be on the streets soon
More >


Multimedia Thumb

Florida Hospital Fire

Fire halts construction project at Tampa cancer center.
More >


Multimedia Thumb

The AmbuBus®, Bus Stretcher Conversion Kit - EMS Today 2013

AmbuBus®, Bus Stretcher all-hazards preparedness & response tool
Watch It >


Multimedia Thumb

Braun Ambulances' EZ Door Forward

Helps to create a safer ambulance module.
Watch It >


Multimedia Thumb

LMA MAD Nasal™

Needle-free intranasal drug delivery.
Watch It >


More Product Videos >